It is a pharma private limited company based in Delhi, Delhi, India, established in 2004.
2004 | Delhi, Delhi, India | ActiveSkytech Pharma Private Limited, a active private limited company, was established on 01 July 2004 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24233DL2004PTC127312. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.17 M.
It upholds a compliant status. Its leadership includes Pinky Jindal (Director), Jatin Jindal (Director), Mannu Gupta (Director). Past directors included Rajender Kumar, Kiran Rani Jindal, Shaminder Kumar. It holds ₹1.30 Cr open charges and ₹5.00 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Property No. 87, Ground Floor, Phase-2, Badli, Insustrial Estate, Badli, Delhi, Delhi, 110042.
U24233DL2004PTC127312
127312
01 July 2004
₹0.20 M
₹0.17 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Skytech Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pinky Jindal | Director | 31 Mar 2008 | Current |
| Jatin Jindal | Director | 01 Apr 2015 | Current |
| Mannu Gupta | Director | 16 Dec 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 11 Dec 2015 | Past |
| Pramod Abcsdd | Director | 31 Mar 2015 | Past |
| Pramod Abcsdd | Director | 11 Dec 2015 | Past |
| Pramod Abcsdd | Director | 31 Mar 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Skytech Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 13.39% decrease. The company also saw a slight decrease in profitability, with a 5.08% decrease in profit. The company's net worth moved up by a moderate rise of 6.36%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Skytech Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹13,000,000.00
₹5,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Nov 2024 | Hdfc Bank Limited | ₹1.30 Cr | Open |
| 23 Jul 2011 | Central Bank Of India | ₹5.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Skytech Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Skytech Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skytech Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Hdfc Bank Limited amounted to Rs. 13.00 M with Charge ID 101031878 was registered on 30 Nov 2024. was completed.
The activity Skytech Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Skytech Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
The activity A charge registered on 23 Jul 2011 via Charge ID 10304021 with Central Bank Of India was fully satisfied on 14 Feb 2017. was completed.
Mannu Gupta was appointed as a Director was appointed as a Director on 16 Dec 2015 & has been associated with this company since 10 years 7 days . was recorded as a recent event.
Jatin Jindal was appointed as a Director was appointed as a Director on 01 Apr 2015 & has been associated with this company since 10 years 8 months . was recorded as a recent event.
The CIN of Skytech Pharma Private Limited is U24233DL2004PTC127312.
Skytech Pharma Private Limited is headquartered at Property No. 87, Ground Floor, Phase-2, Badli, Insustrial Estate, Badli, Delhi, Delhi, 110042.
Skytech Pharma Private Limited was incorporated on 01 July 2004.
The current directors of Skytech Pharma Private Limited are
The primary industry of Skytech Pharma Private Limited is Trade.
Skytech Pharma Private Limited is unlisted.
The authorized capital of Skytech Pharma Private Limited is ₹0.20 M, and the paid-up capital is ₹0.17 M.
The compliance status of Skytech Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX